Literature DB >> 15385076

Prophylactic bilateral mastectomy for breast cancer prevention.

Kelly A Metcalfe1.   

Abstract

Prophylactic bilateral mastectomy, or preventive removal of the breasts, is an option for women who are at increased risk of developing breast cancer. Among the highest risk groups are those women with a significant family history of breast cancer and those with a known genetic predisposition to the disease. There are many issues surrounding prophylactic mastectomy. Recent research has demonstrated that prophylactic mastectomy may be effective in preventing breast cancer in high-risk women, as well as those with a known BRCA1/2 mutation. The limited research that has been done on the psychosocial implications of the preventive surgery suggests that prophylactic mastectomy may be effective in reducing distress levels in high-risk women and that most women who have had the surgery do not experience psychosocial difficulties. Overall, women who have had prophylactic mastectomy are satisfied with their decision to have the preventive surgery. However, women who choose prophylactic mastectomy may differ compared with those who do not. The results may not be generalizable to all high-risk women. Counseling of high-risk women, specifically those with a BRCA1 or BRCA2 mutation, should include a discussion of prophylactic mastectomy, including the medical and psychosocial risks and benefits.

Entities:  

Mesh:

Year:  2004        PMID: 15385076     DOI: 10.1089/jwh.2004.13.822

Source DB:  PubMed          Journal:  J Womens Health (Larchmt)        ISSN: 1540-9996            Impact factor:   2.681


  4 in total

1.  Multimodality breast cancer screening in women with a familial or genetic predisposition.

Authors:  I Trop; L Lalonde; M H Mayrand; J David; N Larouche; D Provencher
Journal:  Curr Oncol       Date:  2010-06       Impact factor: 3.677

2.  The inhibition and treatment of breast cancer with poly (ADP-ribose) polymerase (PARP-1) inhibitors.

Authors:  Joseph A De Soto; Xianyan Wang; Yohei Tominaga; Rui-Hong Wang; Liu Cao; Wenhui Qiao; Cuiling Li; Xiaoling Xu; Amanda P Skoumbourdis; Sheila A Prindiville; Craig J Thomas; Chu-Xia Deng
Journal:  Int J Biol Sci       Date:  2006-06-10       Impact factor: 6.580

3.  Factors associated with contralateral preventive mastectomy.

Authors:  Danny Yakoub; Eli Avisar; Tulay Koru-Sengul; Feng Miao; Stacey L Tannenbaum; Margaret M Byrne; Frederick Moffat; Alan Livingstone; Dido Franceschi
Journal:  Breast Cancer (Dove Med Press)       Date:  2015-01-07

Review 4.  Decision making for breast cancer prevention among women at elevated risk.

Authors:  Tasleem J Padamsee; Celia E Wills; Lisa D Yee; Electra D Paskett
Journal:  Breast Cancer Res       Date:  2017-03-24       Impact factor: 6.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.